what happens when you stop tirzepatide taking semaglutide or tirzepatide? – QYRAL Rebound Weight Gain After Stopping

TRIUMPH-1 ran for 80 weeks, roughly 18 months

Nausea and emesis are a barrier to GLP-1 receptor agonist therapy, and in the central nervous system GIP receptor agonism appears to attenuate nausea and suppress appetite, features that also help GLP-1 receptor agonism promote a negative energy balance

Multiple Endocrine Neoplasia Syndrome (MEN2) : Individuals with MEN2 are at increased risk for developing MTC and should also avoid GLP-1 medications

When you have a fat reduction treatment, whether thats by liposuction, CoolSculpting, SculpSure, Kybella, or any of the other methods we offer, youre removing those fat cells along with the fat